Dr. Jimmy Wei is currently the Chief Business Officer of Inmagene Biopharmaceuticals. His responsibilities include corporate business development, finance and human resources. Before joining Inmagene, Dr. Wei has nearly 20 years of China biotech business development and investment experience. Dr. Wei participated the formation of multiple leading biotech companies in China, including ZAI Lab, iMab, Oncologie, XW Lab and JHL Biotech.
Dr. Wei has been the founding partner of Pivotal Bioventure and I-Bridge Capital, in addition to the venture partner of KPCB China. Prior to join KPCB, Jimmy was the Senior Vice President and head of business development at Hutchison MediPharma, where he led the effort to set up multiple partnerships with US and European pharmaceutical companies.
Dr. Wei received a Ph.D. in Biochemistry from North Carolina State University. He also holds an M.B.A. from Darden Business School, University of Virginia and a B.S. degree in Biology from Wuhan University.